Pediatric Fungal Keratitis: Predisposing Factors, Clinical Features, and Outcomes During a 24-Year Study

Ahyan Ilman Qudsi1, Zhenyu Wei1, Zijun Zhang1

  • 1Beijing Institute of Ophthalmology, Beijing Tongren Eye Centre, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Insights

Pediatric fungal keratitis (FK) in North China is often caused by trauma, with Fusarium and Aspergillus as common culprits. Amphotericin B shows effectiveness, and early intervention is key for better outcomes in pediatric FK.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Pediatric fungal keratitis (FK) poses a significant threat to vision in children.
  • Understanding regional trends in causative fungi and their susceptibility is crucial for effective treatment.

Purpose of the Study:

  • To analyze the clinical characteristics, antifungal susceptibility, and treatment outcomes of pediatric FK.
  • To identify key risk factors and predictors of treatment duration in pediatric FK cases.

Main Methods:

  • Retrospective analysis of 88 pediatric FK cases from July 2000 to October 2023 at Beijing Tongren Hospital.
  • Data collected included demographics, predisposing factors, clinical signs, microbiological findings, treatment regimens, and patient outcomes.
  • Fungal identification was confirmed by culture or microscopy.

Main Results:

  • Trauma, particularly from toys and writing tools, was the leading predisposing factor (35.2%).
  • Common clinical features included dense infiltrates (100%), feathery margins (69.2%), and multifocal lesions (38.5%).
  • Fusarium (43.9%) and Aspergillus (25.8%) were the most common fungal isolates; Amphotericin B demonstrated in vitro and clinical efficacy.

Conclusions:

  • Fusarium and Aspergillus are predominant pathogens in North China's pediatric FK, with trauma as the primary risk factor.
  • Amphotericin B is an effective antifungal agent for pediatric FK.
  • Early diagnosis and prompt treatment are essential to improve visual outcomes and reduce treatment duration, with ocular surgery and toddler age being significant predictors.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
425
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.2K